N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide

C110H143F3N18O11S — CID 159508212

IUPACN-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide
SMILESCCC(C(=O)NC1CCN(C)C1c1ccc(C)cc1)N1CCCC1=O.Cc1ccc(C2C(NC(=O)Cc3cc(C)[nH]n3)CCN2C)cc1.Cc1ccc(C2C(NC(=O)Cc3cccnc3)CCN2C)cc1F.Cc1ccc(C2C(NC(=O)Cc3cccs3)CCN2C)cc1F.Cc1ccc(C2C(NC(=O)Cc3ccon3)CCN2C)cc1F.Cc1ccc(C2CN(CCO)CC2NC(=O)CN2CCCCC2=O)o1
InChIInChI=1S/C20H29N3O2.C19H22FN3O.C18H21FN2OS.C18H24N4O.C18H27N3O4.C17H20FN3O2/c1-4-17(23-12-5-6-18(23)24)20(25)21-16-11-13-22(3)19(16)15-9-7-14(2)8-10-15;1-13-5-6-15(11-16(13)20)19-17(7-9-23(19)2)22-18(24)10-14-4-3-8-21-12-14;1-12-5-6-13(10-15(12)19)18-16(7-8-21(18)2)20-17(22)11-14-4-3-9-23-14;1-12-4-6-14(7-5-12)18-16(8-9-22(18)3)19-17(23)11-15-10-13(2)20-21-15;1-13-5-6-16(25-13)14-10-20(8-9-22)11-15(14)19-17(23)12-21-7-3-2-4-18(21)24;1-11-3-4-12(9-14(11)18)17-15(5-7-21(17)2)19-16(22)10-13-6-8-23-20-13/h7-10,16-17,19H,4-6,11-13H2,1-3H3,(H,21,25);3-6,8,11-12,17,19H,7,9-10H2,1-2H3,(H,22,24);3-6,9-10,16,18H,7-8,11H2,1-2H3,(H,20,22);4-7,10,16,18H,8-9,11H2,1-3H3,(H,19,23)(H,20,21);5-6,14-15,22H,2-4,7-12H2,1H3,(H,19,23);3-4,6,8-9,15,17H,5,7,10H2,1-2H3,(H,19,22)
InChIKeyMAGOTYIAUKREJM-UHFFFAOYSA-N
MW1982.53 g/mol
LogP13.02
Rot. Bonds27

About N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide

N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide (PubChem CID 159508212) has the molecular formula C110H143F3N18O11S and a molecular weight of 1982.53 g/mol. Its IUPAC name is N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide.

Molecular Properties

Compound NameN-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide
PubChem CID159508212
Molecular FormulaC110H143F3N18O11S
Molecular Weight1982.53 g/mol
Exact Mass1981.09
IUPAC NameN-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide
SMILESCCC(C(=O)NC1CCN(C)C1c1ccc(C)cc1)N1CCCC1=O.Cc1ccc(C2C(NC(=O)Cc3cc(C)[nH]n3)CCN2C)cc1.Cc1ccc(C2C(NC(=O)Cc3cccnc3)CCN2C)cc1F.Cc1ccc(C2C(NC(=O)Cc3cccs3)CCN2C)cc1F.Cc1ccc(C2C(NC(=O)Cc3ccon3)CCN2C)cc1F.Cc1ccc(C2CN(CCO)CC2NC(=O)CN2CCCCC2=O)o1
InChIInChI=1S/C20H29N3O2.C19H22FN3O.C18H21FN2OS.C18H24N4O.C18H27N3O4.C17H20FN3O2/c1-4-17(23-12-5-6-18(23)24)20(25)21-16-11-13-22(3)19(16)15-9-7-14(2)8-10-15;1-13-5-6-15(11-16(13)20)19-17(7-9-23(19)2)22-18(24)10-14-4-3-8-21-12-14;1-12-5-6-13(10-15(12)19)18-16(7-8-21(18)2)20-17(22)11-14-4-3-9-23-14;1-12-4-6-14(7-5-12)18-16(8-9-22(18)3)19-17(23)11-15-10-13(2)20-21-15;1-13-5-6-16(25-13)14-10-20(8-9-22)11-15(14)19-17(23)12-21-7-3-2-4-18(21)24;1-11-3-4-12(9-14(11)18)17-15(5-7-21(17)2)19-16(22)10-13-6-8-23-20-13/h7-10,16-17,19H,4-6,11-13H2,1-3H3,(H,21,25);3-6,8,11-12,17,19H,7,9-10H2,1-2H3,(H,22,24);3-6,9-10,16,18H,7-8,11H2,1-2H3,(H,20,22);4-7,10,16,18H,8-9,11H2,1-3H3,(H,19,23)(H,20,21);5-6,14-15,22H,2-4,7-12H2,1H3,(H,19,23);3-4,6,8-9,15,17H,5,7,10H2,1-2H3,(H,19,22)
InChIKeyMAGOTYIAUKREJM-UHFFFAOYSA-N
XLogP13.02
TPSA335.63 Ų
H-Bond Donors8
H-Bond Acceptors21
Rotatable Bonds27
Heavy Atoms143
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001982.53
LogP ≤ 513.02
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1021

Analyze N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide?
The IUPAC name of N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide (CID 159508212) is N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide.
What is the SMILES notation for N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide?
The canonical SMILES for N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide is CCC(C(=O)NC1CCN(C)C1c1ccc(C)cc1)N1CCCC1=O.Cc1ccc(C2C(NC(=O)Cc3cc(C)[nH]n3)CCN2C)cc1.Cc1ccc(C2C(NC(=O)Cc3cccnc3)CCN2C)cc1F.Cc1ccc(C2C(NC(=O)Cc3cccs3)CCN2C)cc1F.Cc1ccc(C2C(NC(=O)Cc3ccon3)CCN2C)cc1F.Cc1ccc(C2CN(CCO)CC2NC(=O)CN2CCCCC2=O)o1.
What is the InChIKey of N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide?
The InChIKey is MAGOTYIAUKREJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H29N3O2.C19H22FN3O.C18H21FN2OS.C18H24N4O.C18H27N3O4.C17H20FN3O2/c1-4-17(23-12-5-6-18(23)24)20(25)21-16-11-13-22(3)19(16)15-9-7-14(2)8-10-15;1-13-5-6-15(11-16(13)20)19-17(7-9-23(19)2)22-18(24)10-14-4-3-8-21-12-14;1-12-5-6-13(10-15(12)19)18-16(7-8-21(18)2)20-17(22)11-14-4-3-9-23-14;1-12-4-6-14(7-5-12)18-16(8-9-22(18)3)19-17(23)11-15-10-13(2)20-21-15;1-13-5-6-16(25-13)14-10-20(8-9-22)11-15(14)19-17(23)12-21-7-3-2-4-18(21)24;1-11-3-4-12(9-14(11)18)17-15(5-7-21(17)2)19-16(22)10-13-6-8-23-20-13/h7-10,16-17,19H,4-6,11-13H2,1-3H3,(H,21,25);3-6,8,11-12,17,19H,7,9-10H2,1-2H3,(H,22,24);3-6,9-10,16,18H,7-8,11H2,1-2H3,(H,20,22);4-7,10,16,18H,8-9,11H2,1-3H3,(H,19,23)(H,20,21);5-6,14-15,22H,2-4,7-12H2,1H3,(H,19,23);3-4,6,8-9,15,17H,5,7,10H2,1-2H3,(H,19,22).
What are the key properties of N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide?
N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide has a molecular weight of 1982.53 g/mol, XLogP of 13.02, 27 rotatable bonds, 8 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-(1,2-oxazol-3-yl)acetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-pyridin-3-ylacetamide;N-[2-(3-fluoro-4-methylphenyl)-1-methylpyrrolidin-3-yl]-2-thiophen-2-ylacetamide;N-[1-(2-hydroxyethyl)-4-(5-methylfuran-2-yl)pyrrolidin-3-yl]-2-(2-oxopiperidin-1-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(5-methyl-1H-pyrazol-3-yl)acetamide;N-[1-methyl-2-(4-methylphenyl)pyrrolidin-3-yl]-2-(2-oxopyrrolidin-1-yl)butanamide is sourced from PubChem (CID 159508212), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).